159 related articles for article (PubMed ID: 22895238)
1. Hepatitis B reactivation in cancer patients: role of prechemotherapy screening and antiviral prophylaxis.
Kawsar HI; Shahnewaz J; Gopalakrishna KV; Spiro TP; Daw HA
Clin Adv Hematol Oncol; 2012 Jun; 10(6):370-8. PubMed ID: 22895238
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.
Yeo W; Chan PK; Hui P; Ho WM; Lam KC; Kwan WH; Zhong S; Johnson PJ
J Med Virol; 2003 Aug; 70(4):553-61. PubMed ID: 12794717
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.
Koo YX; Tan DS; Tan IB; Tao M; Chow WC; Lim ST
Cancer; 2010 Jan; 116(1):115-21. PubMed ID: 19899164
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis.
Mandalà M; Fagiuoli S; Francisci D; Bruno R; Merelli B; Pasulo L; Tondini C; Labianca R; Roila F
Crit Rev Oncol Hematol; 2013 Jul; 87(1):12-27. PubMed ID: 23313021
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention.
Mindikoglu AL; Regev A; Schiff ER
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1076-81. PubMed ID: 16861051
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation.
Idilman R; Arat M
Expert Rev Anti Infect Ther; 2011 Aug; 9(8):641-52. PubMed ID: 21819330
[TBL] [Abstract][Full Text] [Related]
7. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
Koo YX; Tay M; Teh YE; Teng D; Tan DS; Tan IB; Tai DW; Quek R; Tao M; Lim ST
Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
[TBL] [Abstract][Full Text] [Related]
8. HBV disease: HBsAg carrier and occult B infection reactivation in haematological setting.
Marinone C; Mestriner M
Dig Liver Dis; 2011 Jan; 43 Suppl 1():S49-56. PubMed ID: 21195372
[TBL] [Abstract][Full Text] [Related]
9. Screening for hepatitis B in chemotherapy patients: survey of current oncology practices.
Tran TT; Rakoski MO; Martin P; Poordad F
Aliment Pharmacol Ther; 2010 Jan; 31(2):240-6. PubMed ID: 19814747
[TBL] [Abstract][Full Text] [Related]
10. A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
Long M; Jia W; Li S; Jin L; Wu J; Rao N; Feng H; Chen K; Deng H; Liu F; Su F; Song E
Breast Cancer Res Treat; 2011 Jun; 127(3):705-12. PubMed ID: 21445574
[TBL] [Abstract][Full Text] [Related]
11. The difficulties of managing severe hepatitis B virus reactivation.
Roche B; Samuel D
Liver Int; 2011 Jan; 31 Suppl 1():104-10. PubMed ID: 21205146
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B and cancer: A practical guide for the oncologist.
Bozza C; Cinausero M; Iacono D; Puglisi F
Crit Rev Oncol Hematol; 2016 Feb; 98():137-46. PubMed ID: 26657667
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.
Lubel JS; Angus PW
J Gastroenterol Hepatol; 2010 May; 25(5):864-71. PubMed ID: 20546439
[TBL] [Abstract][Full Text] [Related]
14. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies.
Lalazar G; Rund D; Shouval D
Br J Haematol; 2007 Mar; 136(5):699-712. PubMed ID: 17338776
[TBL] [Abstract][Full Text] [Related]
15. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.
Huang L; Li J; Lau WY; Yan J; Zhou F; Liu C; Zhang X; Shen J; Wu M; Yan Y
J Gastroenterol Hepatol; 2012 Jan; 27(1):158-64. PubMed ID: 21871026
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
[TBL] [Abstract][Full Text] [Related]
17. [Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].
Fan LY; Zhou Z; Zhong S; Ling N; Wang ZY; Shi XF; Zhang DZ; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):429-33. PubMed ID: 19567021
[TBL] [Abstract][Full Text] [Related]
18. [Immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection].
Sato K
Gan To Kagaku Ryoho; 2011 Feb; 38(2):161-8. PubMed ID: 21368477
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
Steinberg JL; Yeo W; Zhong S; Chan JY; Tam JS; Chan PK; Leung NW; Johnson PJ
J Med Virol; 2000 Mar; 60(3):249-55. PubMed ID: 10630955
[TBL] [Abstract][Full Text] [Related]
20. Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients.
Yeo W; Ho WM; Hui P; Chan PK; Lam KC; Lee JJ; Johnson PJ
Breast Cancer Res Treat; 2004 Dec; 88(3):209-15. PubMed ID: 15609123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
